[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357757-105":59,"doc-detail-357757-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","breast-cancer-survival-prediction-using-machine-learning-and-multimodal-data-for-personalized-care-plan-research","Breast cancer survival prediction using machine learning and multimodal data for personalized care plan - Research","","Breast cancer survival prediction using time-stratified analysis combines tumor characteristics, disease stage, and patient features to support personalized care planning with machine learning. The study models nonlinear links between inputs and mortality risk and reflects changes in patient characteristics over time. Using multimodal data from 3,476 patients with 43 features, six algorithms including XGBoost and Random Forest are evaluated for survival rates under multiple horizons. XGBoost achieves over 90% accuracy, supported by SHAP explanations and validated with nested 5-fold cross-validation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/breast-cancer-survival-prediction-using-machine-learning-and-multimodal-data-for-personalized-care-plan-research/357757/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/breast-cancer-survival-prediction-using-machine-learning-and-multimodal-data-for-personalized-care-plan-research/357757.png","ImageObject",300,407,{"name":92,"@type":93},"kopisore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and features are used to predict breast cancer survival?","Question",{"text":112,"@type":113},"The study uses multimodal data from 3,476 breast cancer patients, comprising 43 features across tumor, disease, and patient characteristics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which machine learning models are evaluated, and how is performance assessed?",{"text":117,"@type":113},"Six models are evaluated: XGBoost, Logistic Regression, Random Forest, Decision Tree, AdaBoost, and Multilayer Perceptron. Performance is assessed using accuracy, precision, F1 score, and recall, with 5-fold cross-validation and nested cross-validation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does SHAP contribute to the survival prediction results?",{"text":121,"@type":113},"SHAP provides interpretability by identifying the top predictors and indicating how lower or higher feature values relate to longer or shorter breast cancer survival, such as DCIS and Ki-67 values and lymph node involvement.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357757,1790905160,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Rady Raz etal. BMC Cancer (2026) 26:951 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16283-w](https://doi.org/10.1186/s12885-026-16283-w)  \nRESEARCH Open Access  \nBreast cancer survival prediction using machine learning and multimodal data for personalized care plan  \nNasibeh Rady Raz1,2*, Nahid Nafissi 1,3,2*, Ebrahim Babaee4 and Pedram Fadavi 1,5  \nAbstract  \nThis paper presents a time-stratified breast cancer survival analysis that incorporates tumor characteristics, disease stage, and patient features, using machine learning (ML) algorithms to support personalized care planning. Considering nonlinear relationships between input data and the risk of death, as well as the dynamics of patient characteristics over time, we utilize 6 ML algorithms, including XGBoost, Logistic Regression, Random Forest, Decision Tree, AdaBoost, and Multilayer Perceptron, for less than 6 months, 6 months, 1-, 2-, 3-, 5-, and 10-year survival rates prediction. We utilize multimodal data from 3,476 breast cancer patients, comprising 43 features. XGBoost outperforms the rest, achieving an accuracy of over 90% . The top five predictors, using Shapley Additive exPlanations (SHAP), include DCIS, Ki-67, age, feeding, and lymph node grade. SHAP analysis indicated that lower values of DCIS and Ki-67, lower lymph node and tumor grade, less sentinel lymph node involvement, higher age, longer duration of breastfeeding, lower tumor size, medullary tumor type, PR+, ER+, less positive node, more pregnancy, DCIS pathology class, BCS surgery type for early-stage, lower tumor stage, no necrosis, HER2-, no family history, and no calcification are result in longer breast cancer survival. Furthermore, we validate the model’s performance using 5-fold cross-validation (CV) and nested CV. We also evaluate model performance using accuracy, precision, F1 score, and recall. All results show the proposed method outperforms. This paper presents clinical, molecular, and demographic insights into survival analysis, utilizing explainable ML techniques to support personalized treatment decisions.  \nKeywords Artificial Intelligence, Survival Analysis, Breast Cancer, Machine Learning, Personalized Treatment  \n*Correspondence: Nasibeh Rady Raz[radyraz.n@iums.ac.ir](radyraz.n@iums.ac.ir)[ ](radyraz.n@iums.ac.ir)Nahid Nafissi [nafissi.n@iums.ac.ir](nafissi.n@iums.ac.ir)  \n1Breast Cancer Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran  \n2Department of Artificial Intelligence in Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran 3Department of Breast Diseases Surgery, School of Medicine, Iran University of Medical Sciences, Tehran, Iran  \n4Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Community and Family Medicine Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran 5Department of Radiation Oncology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran  \nIntroduction  \nBreast cancer, as the most common malignancy in women worldwide, is curable in early stages and nonmetastatic cases [1]. In the case of distant metastases, it is considered incurable with available therapies. Additionally, breast cancer is a heterogeneous disease at the molecular level with various molecular features, such as HER2, estrogen, and progesterone receptors, in which treatment varies based on the molecular subtype.  \nBreast cancer treatment should be performed both locally and systemically [2], including surgery, radiotherapy, endocrine therapy, chemotherapy, anti-HER2  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Com","cbCaiuZPKWvWXM8H","https://ap.wps.com/l/cbCaiuZPKWvWXM8H","pdf",1948597,14,"English","# Abstract\n# Introduction\n## Clinical background and heterogeneity\n## Survival analysis and challenges\n## Classical modeling and limitations\n# Methods and model evaluation\n## Machine learning algorithms\n## Multimodal features and dataset\n## Cross-validation strategy\n## Metrics and performance\n# Explainable AI insights\n## SHAP feature attribution\n# Conclusion","[{\"question\":\"What data and features are used to predict breast cancer survival?\",\"answer\":\"The study uses multimodal data from 3,476 breast cancer patients, comprising 43 features across tumor, disease, and patient characteristics.\"},{\"question\":\"Which machine learning models are evaluated, and how is performance assessed?\",\"answer\":\"Six models are evaluated: XGBoost, Logistic Regression, Random Forest, Decision Tree, AdaBoost, and Multilayer Perceptron. Performance is assessed using accuracy, precision, F1 score, and recall, with 5-fold cross-validation and nested cross-validation.\"},{\"question\":\"How does SHAP contribute to the survival prediction results?\",\"answer\":\"SHAP provides interpretability by identifying the top predictors and indicating how lower or higher feature values relate to longer or shorter breast cancer survival, such as DCIS and Ki-67 values and lymph node involvement.\"}]","Breast cancer survival prediction using machine learning and multimodal data for personalized care plan - Research | PDF",1790131677,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee89db84dac8c44a9e434121c80e382d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1521822b9cd79e7560238ceea6e05f8.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b999a64e1205a5b95d0fdc42c5ebd04c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb32c5ba09bdbb0c80f9008a4c4ef1a0.webp",980,1306]